Loading…
CG Oncology, Inc.
CG Oncology, Inc. (CGON) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Dallas, United States and has 142 employees. The company is worth $5.54B. Revenue was $4.04M in fiscal 2025, up 254.7% from the year before. It reported a net loss of $161M. The share price is 22.8% below its 52-week high of $80.97. One of the 38 superinvestors we track held it at the end of Q2 2026: Cliff Asness (AQR Capital Management), at $7.28M. Over the last 30 days, company insiders sold $62.07K of its stock on the open market and bought none. All of those sales were scheduled in advance under 10b5-1 plans.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▲ +60.6% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 2 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 |
|---|---|---|---|
| Year-end price | $41.52 | $28.68 | |
| P/S | — | 867.8x | 1919.1x |
| P/B | — | 4.7x | 3.0x |
| EPS | -$2.08 | -$1.41 | |
| Profit margin | — | -3985.02% | -7729.50% |
| ROE | — | -21.39% | -12.00% |
Median of the years shown; P/E years above 200x are left out.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| WAYWaystar Holding Corp. | $28.98 | 41.4x | 1.4x | 0.00% | 3.77% | $5.56B |
| RDNTRadNet, Inc. | $70.26 | — | 5.0x | 0.00% | 1.50% | $5.53B |
| MMSIMerit Medical Systems Inc | $93.94 | 37.6x | 3.3x | 0.00% | 9.19% | $5.61B |
| COGTCogent Biosciences, Inc. | $31.31 |
| — |
| 11.5x |
| 0.00% |
| -109.74% |
| $5.43B |
| GRALGRAIL, Inc. | $127.06 | — | 2.2x | 0.00% | -16.12% | $5.68B |
| MIRMMirum Pharmaceuticals, Inc. | $83.10 | — | — | 0.00% | -702.97% | $5.4B |